Frankfurt - Delayed Quote EUR
Pharvaris N.V. (9EN.F)
14.00
-0.30
(-2.10%)
As of 8:05:02 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 6 |
| Avg. Estimate | -- | -- | -- | 1.96M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 11.73M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 9EN.F | -- | -- | -- | -- |
| S&P 500 | 13.17% | 2.85% | 7.92% | 13.78% |
Upgrades & Downgrades
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 5/14/2025 |
| Initiated | Cantor Fitzgerald: Overweight | 4/29/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 3/3/2025 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 1/31/2025 |
| Initiated | Jones Trading: Buy | 9/19/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 9/6/2024 |
Related Tickers
OCS Oculis Holding AG
18.30
+5.90%
NERV Minerva Neurosciences, Inc.
1.5550
-2.20%
LENZ LENZ Therapeutics, Inc.
27.34
-1.05%
KZIA Kazia Therapeutics Limited
3.4000
-3.00%
VTVT vTv Therapeutics Inc.
22.41
+5.16%
REPL Replimune Group, Inc.
7.23
+3.14%
PDSB PDS Biotechnology Corporation
1.3500
+3.05%
OCUL Ocular Therapeutix, Inc.
7.17
+3.46%
SNDX Syndax Pharmaceuticals, Inc.
8.95
-3.56%
FBIO Fortress Biotech, Inc.
1.7800
+7.23%